Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2025-12-25 @ 4:04 AM
NCT ID:
NCT04260802
Brief Summary:
This study will investigate OC-001 as monotherapy, and in combination with, Avelumab, in various cancer types
Study:
NCT04260802
Study Brief:
Protocol Section:
NCT04260802